BDBM698892 (4-((R)-3-hydroxy-3-methylpiperidin-1-yl)-2-((1- (((R)-3-(hydroxymethyl)piperidin-1- yl)methyl)cyclopropyl)methoxy)-5,7-dihydro- 6H-pyrrolo[3,4-d]pyrimidin-6-yl)(3-hydroxy-8- iodonaphthalen-1-yl)methanone::US20240317759, Example 101

SMILES C=CC(=O)N1CCC[C@H]1C#Cc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C

InChI Key InChIKey=INZIONSXEIGDOQ-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 698892   

TargetTyrosine-protein kinase BTK(Human)
Hanmi Pharm. Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 698892BDBM698892(US20260103453, Example 21)
Affinity DataIC50: 105nMAssay Description:JAK1, JAK2, JAK3 and Tyk2 were purchased from Carna Biosciences, Inc. As the substrate, LANCE Ultra ULight-JAK1 Peptide (manufactured by PerkinElmer ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2026
Entry Details
US Patent